Legal status · United States
Is Lanreotide legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Lanreotide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Lanreotide in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Approved for acromegaly, gastroenteropancreatic neuroendocrine tumours and carcinoid syndrome. The neuroendocrine tumour indication is specifically for improving progression-free survival. |
| FDA approval status | FDA-approved for acromegaly, for gastroenteropancreatic neuroendocrine tumours to improve progression-free survival, and for carcinoid syndrome. |
| Human studies cited | 1 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Lanreotide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Lanreotide for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Lanreotide is
A somatostatin analogue that extended progression-free survival in neuroendocrine tumours in a randomised phase 3, which is a hard endpoint that very few peptides on this site can claim.
Somatostatin is the body's universal inhibitory hormone, switching off growth hormone, insulin, glucagon and most gut secretions. Its native half-life is a couple of minutes, so the useful drugs are engineered analogues, and lanreotide is one of two that matter clinically alongside octreotide.
Mechanism: A cyclic octapeptide analogue of somatostatin with high affinity for somatostatin receptor subtypes 2 and 5, formulated as a prolonged-release depot. Activating those receptors, which are G protein-coupled and inhibitory, suppresses hormone secretion from pituitary and neuroendocrine cells and reduces gut motility and secretion.
Regulatory history: FDA-approved for acromegaly, for gastroenteropancreatic neuroendocrine tumours to improve progression-free survival, and for carcinoid syndrome.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Lanreotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Lanreotide in other countries
Frequently asked questions
Is Lanreotide legal in the United States?
Yes. Lanreotide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Approved for acromegaly, gastroenteropancreatic neuroendocrine tumours and carcinoid syndrome. The neuroendocrine tumour indication is specifically for improving progression-free survival.
Can I buy Lanreotide in the United States?
Only with a prescription. Lanreotide is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Approved for acromegaly, gastroenteropancreatic neuroendocrine tumours and carcinoid syndrome. The neuroendocrine tumour indication is specifically for improving progression-free survival.
Is Lanreotide FDA approved?
Yes. FDA status: FDA-approved for acromegaly, for gastroenteropancreatic neuroendocrine tumours to improve progression-free survival, and for carcinoid syndrome.. Current US classification: "FDA-approved, prescription only". On the evidence, 1 human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Lanreotide live on its compound profile.
Lanreotide profileThis page is general information about the regulatory status of Lanreotide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.